Tiziana Life Sciences has signed a deal with strategic partners to support a clinical trial designed to test its experimental nasal therapy foralumab in people with hard-to-treat relapsing-remitting multiple sclerosis (RRMS). Under the signed Memorandum of Understanding (MOU), the collaboration involves Tiziana, The King Abdullah International Medical Research…
Discussion
Among people with relapsing-remitting multiple sclerosis (RRMS), greater physical disability is associated with higher depression severity, according to a small study from Egypt. The study showed that people with RRMS had substantially higher rates of at least moderate depression than people without multiple sclerosis (MS). More severe depression was also…
Discussion
Medically indicated cesarean sections (C-sections) before 39 weeks of gestation, or full term pregnancy, may be more frequent among women with multiple sclerosis (MS) than in those without the disease, a study found. However, this difference was not linked to MS itself, with most commonly reported reasons for early…
Discussion
Reactivation of dormant Epstein-Barr virus (EBV) in immune cells may trigger disease flares in multiple sclerosis (MS), a study showed. The researchers found that EBV reactivation in immune cells is detectable in the weeks and months before an MS relapse. “We believe this work provides foundational insights…
Discussion
An extract from the fruit of the Aegle marmelos plant reduced inflammation and damage to the myelin sheath in a rat model of multiple sclerosis (MS), a study reports. Researchers found that the extract, administered orally over 42 days, also improved motor and memory performance,…
Get regular updates to your inbox.
